GT Healthcare Capital Partners

News, insights, analysis and data

GT Healthcare Capital Partners overview

GT Healthcare Capital Partners contact information

Offices

marker icon22 Pottinger Street, Central, Hong Kong, undefined, Hong Kong
Showing 1 of 2 GT Healthcare Capital Partners offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMr. Marcus Hui
Job titleVice President
LocationHong Kong, Hong Kong
Emaillock image------
user imageMr. Fred Aswad
Job titleVenture Partner
LocationHong Kong, Hong Kong
Emaillock image----------
user imageMs. Nan Jiang
Job titleInvestment Analyst
LocationShanghai, China
Emaillock image-------
user imageDr. MingXi Li
Job titlePartner
LocationShanghai, China
Emaillock image------

Stories that mention GT Healthcare Capital Partners

GI Windows Medical Corp lands $16.4m

West Bridgewater, Massachusetts-based GI Windows Medical Corp, a clinical-stage, privately-held medical device company, has raised $16.4 million in Series A-1 financing.

GI Windows Corp closes $14.6 mln Series A

West Bridgewater, Massachusetts-based GI Windows Corp, a medical device company, has raised $14.6 million in Series A financing.

Oxford Finance provides $60 mln to VC-backed RefleXion Medical

Oxford Finance LLC has provided a $60 million loan to Hayward, California-based RefleXion Medical Inc, a biotargeting oncology company. Armentum Partners served as financial adviser to RefleXion Medical on the financing. RefleXion is backed by TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price Associates, Inc, GT Healthcare Capital Partners, Pfizer Venture Investments and Johnson & Johnson Innovation, JJDC Inc.

RefleXion Medical rakes in over $100 mln Series C

Hayward, California-based RefleXion Medical, a developer of biology-guided radiotherapy system for targeted cancer treatment, has raised more than $100 million in Series C funding. The Rise Fund, an impact investment fund managed by TPG Growth, led the round with participation from other investors that included T. Rowe Price Associates, Inc, GT Healthcare Capital Partners, Sofinnova Partners, KCK Group, Venrock, Pfizer Venture Investments and Johnson & Johnson Innovation – JJDC Inc.